Antiseizure potential of the triple T‐type calcium channel blocker ACT ‐709478 (apinocaltamide) in rodent models
Year: 2025
Type: article
Source: Epilepsia
DOI: 10.1111/epi.18386
Institution: Idorsia Pharmaceuticals Ltd (Switzerland)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409087299
